• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, August 16, 2024

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from the American Medical Association referenced a study published in the August 2022 issue of The American Journal of Managed Care® (AJMC®). The article, “Formulary Restrictions and Stroke Risk in Patients with Atrial Fibrillation,” found that limiting access to non–vitamin K antagonist oral anticoagulants could exacerbate the underuse of anticoagulants and increase the risk of stroke in patients with atrial fibrillation.

A study titled “Inadequate Insurance Coverage for Overweight/Obesity Management,” published in the August 2024 issue of AJMC, was referenced in an article from MedCity News. The study determined that focusing on prevention, treatment, and reducing the impact of stigma are the main keys to addressing the obesity epidemic in America.

Related Videos
Marry Vuong, PharmD, BCPPS
Steven Daveluy, MD, dermatologist, Wayne State University
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Clayton Irvine, PharmD, MBA, MS
2 experts in this video
Amir Fathi, MD, Massachusetts General Hospital
Related Content
AJMC Q&A with Elizabeth Garcia Creighton | Background image credit: ipopba - stock.adobe.com

Navigating Challenges in Pediatric Dermatology Access, Addressing Disparities: Elizabeth Garcia Creighton

August 17th 2025
Article

Pediatric dermatology faces access disparities due to lack of awareness, language barriers, and training gaps in recognizing diverse skin conditions.

Read More

managed care cast banner

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

August 12th 2025
Podcast

Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.

Listen

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com

Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025
Article

Biologic therapies for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) significantly improved ear-related symptoms, enhancing patient quality of life and treatment outcomes.

Read More

AJMC podcast banner

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

August 5th 2025
Podcast

Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.

Listen

patient and doctor | Image: Adobe stock

In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy

August 15th 2025
Article

Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression after CAR T-cell therapy, highlighting treatment challenges and outcomes.

Read More

FIT test | Image credit: TOimages - stock.adobe.com

Pharmacy-Based FIT Screening Could Boost Colorectal Cancer Detection

August 15th 2025
Article

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.